AUS
NZ
UK
CA
USA
IND
Health
Lawsuit for Elanco Animal Health (NYSE: ELAN) Investors: Contact Shareholders Foundation for More Information
November 19, 2024 10:30 AM PST| By Team Kalkine MediaHighlights:,A lawsuit is currently underway involving certain shareholders of Elanco Animal Health Incorporated (NYSE: ELAN).,The lawsuit claims that the company made false or misleading statements regarding its products, including Zenrelia and Crede...
Akari Therapeutics fully complies with Nasdaq listing standards
November 19, 2024 06:59 AM PST| By Team Kalkine MediaHighlights:,Akari Therapeutics has cured its shareholder equity deficiency and regained compliance with Nasdaq Listing Rule 5550(b).,The company's scheduled Nasdaq hearing on November 21 has been canceled as a result of the resolution.,Akari remains...
Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs
November 18, 2024 10:57 PM PST| By Team Kalkine MediaHighlights:,Incyte completes enrollment in other proof-of-concept studies for INCB000262.,The Phase 2 MRGPRX2 study is paused due to preclinical toxicology findings.,Unfavorable Phase 2 results for MRGPRX4 lead to its discontinuation.,Incyte (NASDAQ:...
IQVIA Experiences Surge in Trading Volume - Key Insights
November 18, 2024 04:12 PM PST| By Team Kalkine MediaHeadlines,IQVIA's Recent Trading Spike:,IQVIA Holdings Inc. witnessed an unusual rise in trading activity, attracting market attention.,Analyst Revisions and Ratings:,Various analysts have recently updated their perspectives on IQVIA, reflecting evol...
Healthcare Advances Drive Butterfly Network's Stock Surge
November 18, 2024 04:03 PM PST| By Team Kalkine MediaHeadlines,Butterfly Network's Recent Momentum: Key Takeaways,Stock Update: Butterfly Network Sees Price Increase,Butterfly Network’s Growth Prospects in Focus,Butterfly Network, Inc.,(NYSE:BFLY),experienced a strong trading session on Monday, with sh...
Sensus Healthcare (NASDAQ: SRTS) Reports Q3 2024 Financial Results with 127% Revenue Growth
November 17, 2024 10:56 PM PST| By Team Kalkine MediaHighlights:,Strong Revenue Growth: Sensus Healthcare saw a 127% year-over-year increase in Q3 2024 revenues.,Profitability Shift: The company posted a net income of $1.2 million, reversing a loss from the prior year.,Strategic Expansion: 27 systems s...
AbbVie Boosts Dividend for 2024, Reflecting Strong Financial Health
November 17, 2024 11:15 AM PST| By Team Kalkine MediaHeadlines,AbbVie Increases Dividend Payment for 2024,Company’s Strong Cash Flow Ensures Sustainability of Dividend,AbbVie’s Dividend Growth Reflects Positive Long-Term Trend,AbbVie Inc.,(NYSE:ABBV),will increase its dividend for 2024, offering shareh...
Why Is Evotec Facing a Takeover Amid Financial Challenges?
November 15, 2024 03:59 AM PST| By Team Kalkine MediaHighlights,The biotech sector sees Evotec becoming a focal point for potential acquisitions, drawing interest from multiple entities.,US-based Halozyme Therapeutics proposes to acquire Evotec, highlighting synergies in biotech innovations.,Evotec's o...
Could Victory Capital's Centene Stake Signal Concerns?
November 15, 2024 03:03 AM PST| By Team Kalkine MediaHighlights,Victory Capital Management Inc. increased its stake in Centene Co. by a significant margin during the third quarter.,The institutional investor's holding of Centene shares now accounts for a notable portion of the company's overall equity....
Why Are Short Sellers Focusing More on Atyr Pharma?
November 14, 2024 03:05 AM PST| By Team Kalkine MediaHighlights,Atyr Pharma Inc.,(NASDAQ:ATYR),reported a notable rise in short interest this October.,The latest short interest for Atyr stands at over 1.66 million shares.,Increased activity reflects changes in market sentiment and trading patterns.,Aty...
Is United-Guardian’s Low P/E Ratio a Warning Signal?
November 14, 2024 02:55 AM PST| By Team Kalkine MediaHighlights,United-Guardian, Inc. operates in the healthcare sector, known for providing specialized healthcare products and personal care solutions.,The company’s stock saw a significant monthly dip but has overall positive annual performance.,Despit...
Bio-Rad Laboratories Outlook: Positive Analyst Sentiment and Price Target Increases
November 14, 2024 02:00 AM PST| By Team Kalkine MediaHeadlines,Bio-Rad Laboratories garners positive analyst sentiment.,Price targets show strong growth potential for the company.,Major brokerage firms increase their outlook for Bio-Rad shares.,Bio-Rad Laboratories, Inc.,(NYSE:BIO),continues to generat...
Innate Pharma (NASDAQ: IPHA) Q3 2024 Update: New Leadership, FDA Progress, and Strong Cash Position
November 13, 2024 01:01 AM PST| By Team Kalkine MediaHighlights:,Innate Pharma (NASDAQ: IPHA) secures FDA clearance for IPH4502 and receives positive feedback on lacutamab’s regulatory pathway.,Jonathan Dickinson appointed CEO and Chairman of the Executive Board, signaling leadership transition.,Cash p...
89bio (NASDAQ: ETNB) Upsizes Public Offering to Raise $125 Million, Offering 11.5 Million Shares and Warrants
November 13, 2024 12:37 AM PST| By Team Kalkine MediaHighlights:,89bio (NASDAQ: ETNB) upsizes public offering to 11.45 million shares, raising $125 million.,Pre-funded warrants included in the offering with immediate exercisability.,Underwriters granted option for an additional 2.2 million shares, incr...
Pfizer Receives Upgraded Ratings, Boosting Industry Appeal
November 12, 2024 10:05 PM PST| By Team Kalkine MediaHeadlines,Pfizer receives upgraded ratings from multiple financial firms, highlighting growth prospects.,Analysts from StockNews.com and Evercore ISI elevate Pfizer’s performance rating, with positive outlooks from several others.,Consistent analyst...
Nevro Gains Sector Attention Amid Analyst Ratings Shift
November 12, 2024 03:44 PM PST| By Team Kalkine MediaHeadlines,Nevro secures "Sector Perform" rating from Royal Bank of Canada, receiving mixed assessments from analysts.,Several firms, including JPMorgan and Piper Sandler, have recently updated Nevro's ratings, reflecting cautious evaluations.,Nevro s...
Analysts and Hedge Funds Show Confidence in Danaher
November 12, 2024 10:41 AM PST| By Team Kalkine MediaHeadline,Aigen Investment Management Boosts Holdings in Danaher,Hedge Funds Increase Positions in Danaher,Analyst Ratings Reflect Positive Outlook for Danaher,Aigen Investment Management LP recently acquired a new position in Danaher Co.,(NYSE:DHR),d...
Why Is Janney Montgomery Scott Scaling Back on Edwards Lifesciences?
November 12, 2024 12:50 AM PST| By Team Kalkine MediaHighlights,Janney Montgomery Scott LLC reduced its holdings in Edwards Lifesciences Co. by a notable percentage.,The institutional investor now owns a smaller portion of the medical research company's stock.,The value of Janney's holdings in Edwards...
Regional Health Properties Faces NYSE American Delisting Notice, Plans Appeal
November 11, 2024 10:19 PM PST| By Team Kalkine MediaHeadlines,Regional Health Properties (RHE) has received a notice from NYSE American regarding delisting.,The company has been given the option to appeal this decision, with the process set to continue.,Despite this notice, RHE intends to keep its sec...
Major Institutional Moves in Bristol-Myers Squibb Holdings
November 11, 2024 09:55 PM PST| By Team Kalkine MediaHeadlines,Mesirow Financial Adjusts Holdings in Bristol-Myers Squibb,Institutional Investors Increase Positions in Bristol-Myers Squibb,Growing Stake Among Hedge Funds and Financial Firms,Mesirow Financial Investment Management Inc. recently adjusted...
